Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Management of atrial fibrillation: direct factor IIa and Xa inhibitors or "warfarin shotgun"?

Halperin JL, Goyette RE.

Mt Sinai J Med. 2012 Nov-Dec;79(6):705-20. doi: 10.1002/msj.21346. Review.

PMID:
23239209
2.

Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.

Schneeweiss S, Gagne JJ, Patrick AR, Choudhry NK, Avorn J.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):480-6. doi: 10.1161/CIRCOUTCOMES.112.965988. Epub 2012 Jul 10.

3.

Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.

Berman JP, Halperin JL.

Hosp Pract (1995). 2013 Feb;41(1):37-48. doi: 10.3810/hp.2013.02.1006. Review.

PMID:
23466966
4.

Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.

Lip GY, Larsen TB, Skjøth F, Rasmussen LH.

J Am Coll Cardiol. 2012 Aug 21;60(8):738-46. doi: 10.1016/j.jacc.2012.03.019. Epub 2012 May 9.

5.

Oral anticoagulation in atrial fibrillation: balancing the risk of stroke with the risk of bleed.

Kosar L, Jin M, Kamrul R, Schuster B.

Can Fam Physician. 2012 Aug;58(8):850-8. Review. No abstract available.

6.

Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.

Cheng JW, Barillari G.

J Clin Pharm Ther. 2014 Apr;39(2):118-35. doi: 10.1111/jcpt.12122. Epub 2014 Jan 3. Review.

PMID:
24383983
7.

An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.

Mantha S, Ansell J.

Thromb Haemost. 2012 Sep;108(3):476-84. doi: 10.1160/TH12-02-0093. Epub 2012 Jun 28. Review.

PMID:
22740145
8.

Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.

Lane DA, Wood K.

Circulation. 2015 Apr 21;131(16):e412-5. doi: 10.1161/CIRCULATIONAHA.114.012808. No abstract available.

9.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
10.

Anticoagulation in atrial fibrillation.

Steinberg BA, Piccini JP.

BMJ. 2014 Apr 14;348:g2116. doi: 10.1136/bmj.g2116. Review.

11.

Target-specific oral anticoagulants: practice issues for the clinician.

Plitt A, Giugliano RP.

Hosp Pract (1995). 2014 Aug;42(3):48-61. doi: 10.3810/hp.2014.08.1117. Review.

PMID:
25255406
12.

[Improvements in oral anticoagulant therapy for atrial fibrillation].

Briongos Figuero S, García Santos-Gallego C, Badimón JJ.

Med Clin (Barc). 2013 Dec 7;141(11):487-93. doi: 10.1016/j.medcli.2013.02.015. Epub 2013 Apr 16. Review. Spanish.

PMID:
23597953
13.

Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.

Assiri A, Al-Majzoub O, Kanaan AO, Donovan JL, Silva M.

Clin Ther. 2013 Jul;35(7):967-984.e2. doi: 10.1016/j.clinthera.2013.05.011.

PMID:
23870607
14.

Approach to the new oral anticoagulants in family practice: part 1: comparing the options.

Douketis J, Bell AD, Eikelboom J, Liew A.

Can Fam Physician. 2014 Nov;60(11):989-95. Review.

15.

A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice.

Kasmeridis C, Lip GY, Apostolakis S.

Hosp Pract (1995). 2013 Feb;41(1):61-70. doi: 10.3810/hp.2013.02.1011. Review.

PMID:
23466968
16.

Novel anticoagulants vs warfarin for stroke prevention in atrial fibrillation.

Turagam MK, Velagapudi P, Bongu NR, Kocheril AG.

Cardiovasc Hematol Disord Drug Targets. 2014;14(1):79-86. Review.

PMID:
25088126
17.

[New oral anticoagulants in venous thromboembolism. General practice information on switching, monitoring, pausing].

Oberhofer E.

MMW Fortschr Med. 2015 Jan 19;157(1):24. German. No abstract available.

PMID:
25743289
18.

Alternatives to warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a look back at the state of the field in 2012.

Truffa AA, Lopes RD, Newby LK.

Postgrad Med. 2013 Mar;125(2):146-57. doi: 10.3810/pgm.2013.03.2648. Review.

PMID:
23816780
19.

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.

Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ.

Am J Cardiol. 2012 Aug 1;110(3):453-60. doi: 10.1016/j.amjcard.2012.03.049. Epub 2012 Apr 24. Review.

PMID:
22537354
20.

[New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].

Koziński M, Obońska K, Kubica A, Navarese EP, Kubica J.

Kardiol Pol. 2012;70(10):1053-60. Review. Polish. No abstract available.

Supplemental Content

Support Center